Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib,BMS-690514,neratinib,and TAK-285 - Ding, Chao; Li, Dan; Wang, Yan-Wei; Han, Sai-Sai; Gao, Chun-Mei; Tan, Chun-Yan; Jiang, Yu-Yang (Chinese chemical letters, 2017)
Keywords: Anticancer; HDAC; Kinase; Multitarget; Selectivity; Selectivity; Multitarget; Anticancer; Kinase; HDAC